Sponsors (37)
The bill keeps federal support and boosts public‑health capacity for detecting and responding to vector‑borne diseases through 2030, at the cost of modestly increased federal spending and a small loss of specificity/transparency in advisory language.
State and local public health agencies and hospitals will have increased capacity to detect, report, prevent, and respond to vector‑borne disease outbreaks, improving outbreak detection and response for communities.
State and local public health agencies gain extended federal authorization through 2030 to continue receiving federal support for vector‑borne disease strategy and regional center activities, providing predictable funding and program continuity for health departments.
Patients and communities (including people with chronic conditions and rural populations) face lower risk of service gaps because the bill preserves authorization and continuity for surveillance, prevention, and related programs.
Extending authorizations likely increases federal spending obligations, which could raise costs for taxpayers or crowd out other federal priorities.
Replacing a specific stakeholder reference with a generic "appropriate individuals" may reduce transparency about who advises HHS on tick‑borne disease policy and weaken accountability of advisory processes.
Based on analysis of 1 section of legislative text.
Updates stakeholder wording, adds capacity-building language for vector-borne disease programs, and extends authorizations to 2026–2030.
Extends and updates existing public health authorities that support federal, state, and local work on vector-borne and tick-borne diseases. It revises stakeholder language, adds capacity-building language for identification, reporting, prevention, and response, and extends authorization periods from 2026 through 2030 for the affected programs. The changes amend two provisions of the Public Health Service Act to broaden reference to "appropriate individuals," add a capacity-building clause to program activities, and renew program authorization timelines to cover 2026–2030, affecting HHS programs that fund regional centers and health-department support for vector-borne disease strategy.
Official title: To reauthorize the Kay Hagan Tick Act, and for other purposes.
Introduced July 10, 2025 by Christopher Henry Smith · Last progress July 21, 2026